Cargando…

Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study

BACKGROUND: Opportunistic infections (OIs) are illnesses that attack people with weakened immune systems, such as HIV patients, more frequently and severely. The majority of opportunistic infections (OIs) are the leading causes of morbidity and mortality in HIV/AIDS patients, emerging at the end of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wondifraw, Endalk Birrie, Tefera, Birhanu Desu, Zeleke, Mulusew, Nebyu, Samuel, Tilahun, Lehulu, W/Selassie, Mulugeta, Tefera, Zenebe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758350/
https://www.ncbi.nlm.nih.gov/pubmed/36536709
http://dx.doi.org/10.1016/j.amsu.2022.104910
_version_ 1784852019137216512
author Wondifraw, Endalk Birrie
Tefera, Birhanu Desu
Zeleke, Mulusew
Nebyu, Samuel
Tilahun, Lehulu
W/Selassie, Mulugeta
Tefera, Zenebe
author_facet Wondifraw, Endalk Birrie
Tefera, Birhanu Desu
Zeleke, Mulusew
Nebyu, Samuel
Tilahun, Lehulu
W/Selassie, Mulugeta
Tefera, Zenebe
author_sort Wondifraw, Endalk Birrie
collection PubMed
description BACKGROUND: Opportunistic infections (OIs) are illnesses that attack people with weakened immune systems, such as HIV patients, more frequently and severely. The majority of opportunistic infections (OIs) are the leading causes of morbidity and mortality in HIV/AIDS patients, emerging at the end of the illness. The objective of this study was to assess the incidence and risk factors of opportunistic infections (OIs) in HIV-infected children receiving antiretroviral therapy in public hospitals in Northeast Ethiopia. METHODS: A multicenter retrospective follow-up study was undertaken at public hospitals in northeast Ethiopia from September 1, 2010, to January 30, 2022. A total of 341 HIV-infected children on antiretroviral therapy were included in the study. Data was entered using Epi-Data Manager version 4.6.1, and it was analyzed using STATA version 16.1. The opportunistic infection free-survival time was estimated using the Kaplan-Meier survival curve. Bivariable and multivariable Cox proportional hazard models were used to investigate the determinants of opportunistic infections. RESULTS: The overall incidence rate of opportunistic infections (OIs) was 6.0 (95% CI: 5.0–7.1) per 100 child-years of observation. This study's participants were observed for a minimum of 9 months and a maximum of 122 months, for a total of 21,629 months, or 1802.4 years. Children with WHO clinical stages III and IV (AHR: 1.77; 95% CI: 1.13, 2.77), non-users of Cotrimoxazole Preventive Therapy (CPT) (AHR: 2.10; 95% CI: 1.40, 3.08), and low hemoglobin levels (10 mg/dl) (AHR: 1.88; 95% CI: 1.25, 2.82) were identified as significant predictors of opportunistic infection. CONCLUSION: In this study, the incidence rate of opportunistic infections among HIV-infected children was found to be high when compared to other studies. Low hemoglobin levels (10 mg/dl), low CD4 counts or percentages, clinical stages III and IV, and non-users of CPT were all associated with higher rates of opportunistic infection.
format Online
Article
Text
id pubmed-9758350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97583502022-12-18 Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study Wondifraw, Endalk Birrie Tefera, Birhanu Desu Zeleke, Mulusew Nebyu, Samuel Tilahun, Lehulu W/Selassie, Mulugeta Tefera, Zenebe Ann Med Surg (Lond) Cohort Study BACKGROUND: Opportunistic infections (OIs) are illnesses that attack people with weakened immune systems, such as HIV patients, more frequently and severely. The majority of opportunistic infections (OIs) are the leading causes of morbidity and mortality in HIV/AIDS patients, emerging at the end of the illness. The objective of this study was to assess the incidence and risk factors of opportunistic infections (OIs) in HIV-infected children receiving antiretroviral therapy in public hospitals in Northeast Ethiopia. METHODS: A multicenter retrospective follow-up study was undertaken at public hospitals in northeast Ethiopia from September 1, 2010, to January 30, 2022. A total of 341 HIV-infected children on antiretroviral therapy were included in the study. Data was entered using Epi-Data Manager version 4.6.1, and it was analyzed using STATA version 16.1. The opportunistic infection free-survival time was estimated using the Kaplan-Meier survival curve. Bivariable and multivariable Cox proportional hazard models were used to investigate the determinants of opportunistic infections. RESULTS: The overall incidence rate of opportunistic infections (OIs) was 6.0 (95% CI: 5.0–7.1) per 100 child-years of observation. This study's participants were observed for a minimum of 9 months and a maximum of 122 months, for a total of 21,629 months, or 1802.4 years. Children with WHO clinical stages III and IV (AHR: 1.77; 95% CI: 1.13, 2.77), non-users of Cotrimoxazole Preventive Therapy (CPT) (AHR: 2.10; 95% CI: 1.40, 3.08), and low hemoglobin levels (10 mg/dl) (AHR: 1.88; 95% CI: 1.25, 2.82) were identified as significant predictors of opportunistic infection. CONCLUSION: In this study, the incidence rate of opportunistic infections among HIV-infected children was found to be high when compared to other studies. Low hemoglobin levels (10 mg/dl), low CD4 counts or percentages, clinical stages III and IV, and non-users of CPT were all associated with higher rates of opportunistic infection. Elsevier 2022-11-16 /pmc/articles/PMC9758350/ /pubmed/36536709 http://dx.doi.org/10.1016/j.amsu.2022.104910 Text en © 2022 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Cohort Study
Wondifraw, Endalk Birrie
Tefera, Birhanu Desu
Zeleke, Mulusew
Nebyu, Samuel
Tilahun, Lehulu
W/Selassie, Mulugeta
Tefera, Zenebe
Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title_full Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title_fullStr Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title_full_unstemmed Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title_short Incidence and predictors of common opportunistic infection among HIV -infected children attending antiretroviral treatment clinic at Northeast Ethiopia, public hospitals 2022: A multicenter retrospective follow-up study
title_sort incidence and predictors of common opportunistic infection among hiv -infected children attending antiretroviral treatment clinic at northeast ethiopia, public hospitals 2022: a multicenter retrospective follow-up study
topic Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758350/
https://www.ncbi.nlm.nih.gov/pubmed/36536709
http://dx.doi.org/10.1016/j.amsu.2022.104910
work_keys_str_mv AT wondifrawendalkbirrie incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT teferabirhanudesu incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT zelekemulusew incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT nebyusamuel incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT tilahunlehulu incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT wselassiemulugeta incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy
AT teferazenebe incidenceandpredictorsofcommonopportunisticinfectionamonghivinfectedchildrenattendingantiretroviraltreatmentclinicatnortheastethiopiapublichospitals2022amulticenterretrospectivefollowupstudy